diphenyleneiodonium has been researched along with Chronic Disease in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, WY | 1 |
| Liu, KH | 1 |
| Lin, S | 1 |
| Chen, TY | 1 |
| Tseng, CY | 1 |
| Chen, HY | 1 |
| Wu, HM | 1 |
| Hsu, KS | 1 |
1 other study available for diphenyleneiodonium and Chronic Disease
| Article | Year |
|---|---|
NADPH oxidase 2 as a potential therapeutic target for protection against cognitive deficits following systemic inflammation in mice.
Topics: Animals; Chronic Disease; Cognitive Dysfunction; Enzyme Activation; Enzyme Inhibitors; Inflammation; | 2020 |